Hiroto Bando
Takeda Pharmaceutical Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroto Bando.
Regenerative Therapy | 2018
Kanako Inoo; Hiroto Bando; Yasuhiko Tabata
Introduction The objective of this study is to evaluate the survival and glucose-induced insulin secretion of rat-derived insulinoma cells (INS-1) from their aggregates incorporating different size of gelatin hydrogel microspheres comparing with microspheres-free cell aggregates. Methods The gelatin hydrogel microspheres were prepared by the conventional w/o emulsion method. The INS-1 cells were cultured in a V-bottomed well, combining with or without the gelatin hydrogel microspheres to form their aggregates with or without microspheres. Results When the cell viability, the live cell number, the reductase activity, and the insulin secretion of cell aggregates were evaluated 7 or 14 days after incubation, the cell aggregates incorporating gelatin hydrogel microspheres showed higher cell viability, reductase activity and a larger number of live cells. The cell aggregates incorporating larger size and number of gelatin hydrogel microspheres secreted a larger amount of insulin, compared with those incorporating smaller size and number of microspheres or without microspheres. Conclusion It is conceivable that the incorporation of gelatin hydrogel microspheres in cell aggregates is promising to improve their survival and insulin secretion function.
Regenerative Therapy | 2018
Kanako Inoo; Hiroto Bando; Yasuhiko Tabata
Introduction The objective of this study is to evaluate the insulin secretion of mixed aggregates of insulinoma cells (INS-1) and gelatin hydrogel microspheres after their subcutaneous transplantation. Methods Gelatin hydrogel microspheres were prepared by the conventional w/o emulsion method. Cell aggregates mixed with or without the hydrogel microspheres were encapsulated into a pouched-device of polytetrafluoroethylene membrane. An agarose hydrogel or MedGel™ incorporating basic fibroblast growth factor (bFGF) was subcutaneously implanted to induce vascularization. After the vascularization induction, cell aggregates encapsulated in the pouched-device was transplanted. Results The vascularization had the potential to enable transplanted cell aggregates to enhance the level of insulin secretion compared with those of no vascularization induction. In addition, the insulin secretion of cell aggregates was significantly promoted by the mixing of gelatin hydrogel microspheres even in the pouched-device encapsulated state. Conclusion It is possible that the microspheres mixing gives cells in aggregates better survival condition, resulting in promoted insulin secretion.
Archive | 2003
Yohko Akiyama; Takashi Kurasawa; Hiroto Bando; Naoki Nagahara
Archive | 2006
Hiroto Bando; Takashi Kurasawa
Archive | 2000
Yoko Akiyama; Naoki Nagahara; Hiroto Bando
Archive | 2001
Yohko Akiyama; Satoshi Iinuma; Hiroto Bando
Archive | 2004
Shuji Yoneyama; Hiroto Bando
Archive | 2001
Yohko Akiyama; Satoshi Iinuma; Hiroto Bando
Archive | 2002
Yoko Akiyama; Hiroto Bando; Satoshi Iinuma; 博人 坂東; 洋子 秋山; 智 飯沼
Archive | 2000
Yoko Akiyama; Hiroto Bando; Naoki Nagahara; 博人 坂東; 直樹 永原; 洋子 秋山